Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function

Psychoneuroendocrinology

Volumn 31, Issue 10, 2006, Pages 1266-1277

  Schulte Herbrüggen, Olaf ^a   Chourbaji, Sabine ^b   Ridder, Stephanie ^b   Brandwein, Christiane ^b   Gass, Peter ^b   Hörtnagl, Heide ^a   Hellweg, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

BDNF; Depression; Glucocorticoid receptor; Glucocorticoids; NGF; serotonin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; NERVE GROWTH FACTOR; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; FRONTAL CORTEX; GENOTYPE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; STRESS; WILD TYPE;

AMYGDALA; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CIRCADIAN RHYTHM; CORTICOSTERONE; FEMALE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE GROWTH FACTORS; RECEPTORS, GLUCOCORTICOID; SEROTONIN; STRESS;

EID: 33751317210     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2006.09.008     Document Type: Article

References (76)

1. Allen G.C., Qu X., and Earnest D.J. TrkB-deficient mice show diminished phase shifts of the circadian activity rhythm in response to light. Neurosci. Lett. 378 (2005) 150-155
2. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 20 (1999) 59-61
3. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., and Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389 (1997) 856-860
4. Ansorge M.S., Zhou M., Lira A., Hen R., and Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004) 879-881
5. Banbury Conference. Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron 19 (1997) 755-759
6. Barriga C., Martin M.I., Tabla R., Ortega E., and Rodriguez A.B. Circadian rhythm of melatonin, corticosterone and phagocytosis: effect of stress. J. Pineal Res. 30 (2001) 180-187
7. Berg-von der Emde K., Dees W.L., Hiney J.K., Hill D.F., Dissen G.A., Costa M.E., Moholt-Siebert M., and Ojeda S.R. Neurotrophins and the neuroendocrine brain: different neurotrophins sustain anatomically and functionally segregated subsets of hypothalamic dopaminergic neurons. J. Neurosci. 15 (1995) 4223-4237
8. Bina K.G., and Rusak B. Nerve growth factor phase shifts circadian activity rhythms in Syrian hamsters. Neurosci. Lett. 206 (1996) 97-100
9. Bland S.T., Schmid M.J., Der-Avakian A., Watkins L.R., Spencer R.L., and Maier S.F. Expression of c-fos and BDNF mRNA in subregions of the prefrontal cortex of male and female rats after acute uncontrollable stress. Brain Res. 1051 (2005) 90-99
10. Bova R., Micheli M.R., Qualadrucci P., and Zucconi G.G. BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle. Mol. Brain Res. 57 (1998) 321-324
11. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., and Muglia L.J. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl. Acad. Sci. USA 102 (2005) 473-478
12. Bremner J.D., Staib L.H., Kaloupek D., Southwick S.M., Soufer R., and Charney D.S. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol. Psychiatry 45 (1999) 806-816
13. Bush V.L., Middlemiss D.N., Marsden C.A., and Fone K.C. Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain. J. Neuroendocrinol. 15 (2003) 607-613
14. Cagampang F.R., Yamazaki S., Otori Y., and Inouye S.I. Serotonin in the raphe nuclei: regulation by light and an endogenous pacemaker. Neuroreport 5 (1993) 49-52
15. Cavus I., and Duman R.S. Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol. Psychiatry 54 (2003) 59-69
16. Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 14 (2000) 139-151
17. Chourbaji S., Hellweg R., Brandis D., Zorner B., Zacher C., Lang U.E., Henn F.A., Hörtnagl H., and Gass P. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Mol. Brain Res. 121 (2004) 28-36
18. Colangelo A.M., Follesa P., and Mocchetti I. Differential induction of nerve growth factor and basic fibroblast growth factor mRNA in neonatal and aged rat brain. Mol. Brain Res. 53 (1998) 218-225
19. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., and Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17 (1997) 2295-2313
20. Culman J., Kiss A., and Kvetnansky R. Serotonin and tryptophan hydroxylase in isolated hypothalamic and brain stem nuclei of rats exposed to acute and repeated immobilization stress. Exp. Clin. Endocrinol. 83 (1984) 28-36
21. de Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 (1998) 269-301
22. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog. Brain Res. 126 (2000) 413-431
23. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
24. Dwivedi Y., Mondal A.C., Rizavi H.S., and Conley R.R. Suicide brain is associated with decreased expression of neurotrophins. Biol. Psychiatry 58 (2005) 315-324
25. Fairchild G., Leitch M.M., and Ingram C.D. Acute and chronic effects of corticosterone on 5-HT1A receptor-mediated autoinhibition in the rat dorsal raphe nucleus. Neuropharmacology 45 (2003) 925-934
26. Felice L.J., Felice J.D., and Kissinger P.T. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem. 31 (1978) 1461-1465
27. Gartside S.E., Leitch M.M., and Young A.H. Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology 28 (2003) 1572-1578
28. Givalois L., Naert G., Rage F., Ixart G., Arancibia S., and Tapia-Arancibia L. A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats. Mol. Cell Neurosci. 27 (2004) 280-295
29. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wikstrom A.C., Okret S., Yu Z.Y., Goldstein M., and Steinbusch H. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. Natl. Acad. Sci. USA 83 (1986) 9779-9783
30. Hellweg R., Hock C., and Hartung H.D. An improved rapid and highly sensitive enzyme immunoassay for nerve growth factor. Technique J. Methods Cell Mol. Biol. 1 (1989) 43-48
31. Hellweg R., Thomas H., Arnswald A., von R.S., Kay S., Fink H., Morgenstern R., and Hörtnagl H. Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat. Brain Res. 907 (2001) 100-108
32. Hellweg R., von Arnim C.A., Buchner M., Huber R., and Riepe M.W. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation. Exp. Neurol. 183 (2003) 346-354
33. Hery F., Chouvet G., Kan J.P., Pujol J.F., and Glowinski J. Daily variations of various parameters of serotonin metabolism in the rat brain. II. Circadian variations in serum and cerebral tryptophan levels: lack of correlation with 5-HT turnover. Brain Res. 123 (1977) 137-145
34. Hery F., Rouer E., and Glowinski J. Daily variations of serotonin metabolism in the rat brain. Brain Res. 43 (1972) 445-465
35. Heuser I., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., and Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitryptiline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry 153 (1996) 93-99
36. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
37. Jacobsen J.P., and Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res. 1024 (2004) 183-192
38. Judge S.J., Ingram C.D., and Gartside S.E. Moderate differences in circulating corticosterone alter receptor-mediated regulation of 5-hydroxytryptamine neuronal activity. J. Psychopharmacol. 18 (2004) 475-483
39. Karege F., Vaudan G., Schwald M., Perroud N., and La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Mol. Brain Res. 136 (2005) 29-37
40. Korte M., Staiger V., Griesbeck O., Thoenen H., and Bonhoeffer T. The involvement of brain-derived neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments. J. Physiol. Paris 90 (1996) 157-164
41. Laaris N., Le Poul E., Hamon M., and Lanfumey L. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus-in vitro electrophysiological evidence. Fund. Clin. Pharmacol. 11 (1997) 206-214
42. Landfield P.W., Baskin R.K., and Pitler T.A. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science 214 (1981) 581-584
43. Lang U.E., Jockers-Scherubl M.C., and Hellweg R. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J. Neural Transm. 111 (2004) 387-411
44. Linkowski P., Mendlewicz J., Kerkhofs M., Leclercq R., Golstein J., Brasseur M., Copinschi G., and Van Cauter E. 24-Hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J. Clin. Endocrinol. Metab. 65 (1987) 141-152
45. Lucassen P.J., Muller M.B., Holsboer F., Bauer J., Holtrop A., Wouda J., Hoogendijk W.J., de Kloet E.R., and Swaab D.F. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am. J. Pathol. 158 (2001) 453-468
46. Mitsukawa K., Mombereau C., Lotscher E., Uzunov D.P., van der P.H., Flor P.J., and Cryan J.F. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 31 (2006) 1112-1122
47. Mocchetti I., Spiga G., Hayes V.Y., Isackson P.J., and Colangelo A. Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth factor expression in the rat brain. J. Neurosci. 16 (1996) 2141-2148
48. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., and Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur. J. Neurosci. 14 (2001) 1603-1612
49. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
50. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
51. Pariante C.M., Thomas S.A., Lovestone S., Makoff A., and Kerwin R.W. Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology 29 (2004) 423-447
52. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., and Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16 (1996) 1137-1145
53. Quay W.B. Differences in circadian rhythms in 5-hydroxytryptamine according to brain region. Am. J. Physiol. 215 (1968) 1448-1453
54. Rattiner L.M., Davis M., French C.T., and Ressler K.J. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J. Neurosci. 24 (2004) 4796-4806
55. Rattiner L.M., Davis M., and Ressler K.J. Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn. Mem. 11 (2004) 727-731
56. Rattiner L.M., Davis M., and Ressler K.J. Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist 11 (2005) 323-333
57. Reichardt H.M., Umland T., Bauer A., Kretz O., and Schutz G. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell Biol. 20 (2000) 9009-9017
58. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., and Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25 (2005) 6243-6250
59. Rueter L.E., and Jacobs B.L. Changes in forebrain serotonin at the light-dark transition: correlation with behaviour. Neuroreport 7 (1996) 1107-1111
60. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J. Neurosci. 6 (1986) 2240-2244
61. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57 (2000) 925-935
62. Schaaf M.J., Duurland R., de Kloet E.R., and Vreugdenhil E. Circadian variation in BDNF mRNA expression in the rat hippocampus. Mol. Brain Res. 75 (2000) 342-344
63. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15 (1995) 1768-1777
64. Sperk G. Simultaneous determination of serotonin, 5-hydroxindoleacetic acid, 3,4-dihydroxyphenylacetic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection. J. Neurochem. 38 (1982) 840-843
65. Sperk G., Berger M., Hortnagl H., and Hornykiewicz O. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. Eur. J. Pharmacol. 74 (1981) 279-286
66. Swaab D.F., Bao A.M., and Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4 (2005) 141-194
67. Tapia-Arancibia L., Rage F., Givalois L., and Arancibia S. Physiology of BDNF: focus on hypothalamic function. Front. Neuroendocrinol. 25 (2004) 77-107
68. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 (1999) 99-103
69. von Richthofen S., Lang U.E., and Hellweg R. Effects of different kinds of acute stress on nerve growth factor content in rat brain. Brain Res. 987 (2003) 207-213
70. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., Robinson T.E., Watson S.J., Seasholtz A.F., and Akil H. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc. Natl. Acad. Sci. USA 101 (2004) 11851-11856
71. Weinert D., Eimert H., Erkert H.G., and Schneyer U. Resynchronization of the circadian corticosterone rhythm after a light/dark shift in juvenile and adult mice. Chronobiol. Int. 11 (1994) 222-231
72. Wesemann W., Clement H.W., Gemsa D., Hasse C., Heymanns J., Pohlner K., Schafer F., and Weiner N. Immobilization and light-dark cycle-induced modulation of serotonin metabolism in rat brain and of lymphocyte subpopulations: in vivo voltammetric and FACS analyses. Neuropsychobiology 28 (1993) 91-94
73. Williams L.M., Kemp A.H., Felmingham K., Barton M., Olivieri G., Peduto A., Gordon E., and Bryant R.A. Trauma modulates amygdala and medial prefrontal responses to consciously attended fear. Neuroimage 29 2 (2005) 347-357
74. Wolfer D.P., Crusio W.E., and Lipp H.P. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci. 25 (2002) 336-340
75. Yan Q., Rosenfeld R.D., Matheson C.R., Hawkins N., Lopez O.T., Bennett L., and Welcher A.A. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 78 (1997) 431-448
76. Young A.H. Glucocorticoids, serotonin and mood. Br. J. Psychiatry 165 (1994) 271-272